Priming the Abscopal Effect Using Multifunctional Smart Radiotherapy Biomaterials Loaded with Immunoadjuvants
Open Access
- 12 March 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 8, 56
Abstract
In this study, we investigate the use of multifunctional smart radiotherapy biomaterials (SRBs) loaded with immunoadjuvants for boosting the abscopal effect of local radiotherapy (RT). SRBs were designed similar to currently used inert RT biomaterials, incorporating a biodegradable polymer with reservoir for loading payloads of the immunoadjuvant anti-CD40 monoclonal antibody. Lung (LLC1) tumors were generated both on the right and left flank of each mouse, with the left tumor representing metastasis. The mice were randomized and divided into eight cohorts with four cohorts receiving image-guided RT (IGRT) at 5 Gy and another similar four cohorts at 0 Gy. IGRT and Computed Tomography (CT) imaging were performed using a small animal radiation research platform (SARRP). Tumor volume measurements for both flank tumors and animal survival was assessed over 25 weeks. Tumor volume measurements showed significantly enhanced inhibition in growth for the right flank tumors of mice in the cohort treated with SRBs loaded with CD40 mAbs and IGRT. Results also suggest that the use of polymeric SRBs with CD40 mAbs without RT could generate an immune response, consistent with previous studies showing such response when using anti-CD40. Overall, 60% of mice treated with SRBs showed complete tumor regression during the observation period, compared to 10% for cohorts administered with anti-CD40 mAbs, but no SRB. Complete tumor regression was not observed in any other cohorts. The findings justify more studies varying RT doses and quantifying the immune-cell populations involved when using SRBs. Such SRBs could be developed to replace currently used RT biomaterials, allowing not only for geometric accuracy during RT, but also for extending RT to the treatment of metastatic lesions.Keywords
Funding Information
- Brigham and Women’s Hospital
- National Institutes of Health (R21CA205094)
This publication has 28 references indexed in Scilit:
- Using immunotherapy to boost the abscopal effectNature Reviews Cancer, 2018
- Following the Preclinical Data: Leveraging the Abscopal Effect More EfficaciouslyFrontiers in Oncology, 2017
- Current clinical trials testing the combination of immunotherapy with radiotherapyJournal for ImmunoTherapy of Cancer, 2016
- Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of CancerCancer Research, 2016
- Combining Radiation and Immunotherapy: A New Systemic Therapy for Solid Tumors?Cancer Immunology Research, 2014
- Improved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapiesClinical & Translational Immunology, 2014
- Radiation Therapy to Convert the Tumor Into an In Situ VaccineInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Radiation as an immunological adjuvant: current evidence on dose and fractionationFrontiers in Oncology, 2012
- Cancer and Radiation Therapy: Current Advances and Future DirectionsInternational Journal of Medical Sciences, 2012
- Eradication of established tumors in mice by a combination antibody-based therapyNature Medicine, 2006